Though much has been done in an effort to close them, there are still significant gaps in knowledge and research advancement on outbreaks of infection with Cyclospora cayetanensis. In an effort to increase awareness of these gaps, the United States Food and Drug Administration (FDA) held a Grand Rounds presentation on June 13, 2019, presented…
After molecular testing, half of all travel-acquired ESBL-producing E coli strains qualified as pathogens, despite most being classified as extraintestinal pathogenic or uropathogenic.
Among children under age 5 years with acute gastroenteritis, Lactobacillus reuteri DSM 17938 as an adjunct to rehydration therapy did not reduce the duration of diarrhea compared with placebo.
Backyard flocks of live poultry have been linked with Salmonella outbreaks that have sickened 52 people in 21 states.
The NDA for Talicia for the treatment of Helicobacter pylori (H. pylori) infection has been submitted to the FDA by RedHill Biopharma.
From 2015 to 2018, the incidence of most foodborne infections increased.
Extended-pulsed fidaxomicin is an efficacious treatment for C difficile infection, regardless of baseline factors.
Laboratory-confirmed acute gastroenteritis surveillance in the US showed a dynamic prevalence and incidence variability of outpatient and inpatient community-acquired norovirus
Microbial and metabolic features can distinguish children with irritable bowel syndrome from controls.
The AGA present an updated summary of best practice advice for surveillance of hepatocellular cancer and DAA therapy timing.
